News

AI Transformation Reshaping Big Tech Valuations

New York — United States equity-index futures indicated a mildly higher to flat start for Monday’s session, as investors attempted to stabilize sentiment after last week’s sharp drawdown and heightened volatility. The early tone was “cautious rebound,” with risk appetite constrained by elevated energy …

Stock Market Reaction: Liquidity Relief Drives the Rally

Rocket Pharmaceuticals (NASDAQ: RCKT)emerged as a key outperformer after announcing US Food and Drug Administration accelerated approval for KRESLADI, a gene therapy targeting pediatric patients with severe leukocyte adhesion deficiency-I. The approval represents a pivotal inflection point for the company’s rare disease franchise. Importantly, …

Introduction: FDA Approval Drives Strategic Milestone for Denali

The US sector rotation on 27 March 2026, reveals a highly unusual and skewed momentum environment. As the momentum chart illustrates, capital is not broadening out; it is funneling aggressively into one specific theme, leaving a growing portion of the market struggling in the …

The US equity market on March 27, 2026, experienced a pronounced "risk-off" session, characterized by a sharp sell-off in economically sensitive cyclical sectors and high-valuation growth names. Capital aggressively sought shelter in hard assets and reliable, low-beta dividend payers, signaling elevated anxiety regarding the …